We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+2.6%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.34B
AUM Growth
+$209M
Cap. Flow
+$157M
Cap. Flow %
4.72%
Top 10 Hldgs %
12.01%
Holding
1,564
New
189
Increased
576
Reduced
529
Closed
163

Sector Composition

Rank Sector Weight
1 Energy 11.94%
2 Healthcare 10.62%
3 Industrials 9.8%
4 Technology 9.43%
5 Financials 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RGP
226
DELISTED
REGENCY ENERGY PARTNERS LP COMMON UTS REP LIMITED PART INTS
RGP
$3.55M 0.11%
130,495
+109,445
+520% +$2.93M
GIS icon
227
General Mills
GIS
$19.4B
$3.54M 0.11%
68,336
-102
-0.1% -$5.05K
ANDX
228
DELISTED
Andeavor Logistics LP
ANDX
$3.51M 0.11%
58,249
+2,050
+4% +$118K
GRMN
229
Garmin
GRMN
$57.4B
$3.5M 0.11%
+63,432
New +$3.14M
HAL icon
230
Halliburton
HAL
$26.4B
$3.49M 0.1%
59,324
+3,498
+6% +$187K
OVV icon
231
Ovintiv
OVV
$17B
$3.49M 0.1%
32,680
-6,162
-16% -$583K
SRLN icon
232
State Street Blackstone Senior Loan ETF
SRLN
$5.3B
$3.49M 0.1%
69,769
+8,748
+14% +$438K
ADP icon
233
Automatic Data Processing
ADP
$105B
$3.48M 0.1%
51,364
-154
-0.3% -$10.5K
LHX icon
234
L3Harris
LHX
$50.7B
$3.48M 0.1%
47,593
+19,813
+71% +$1.42M
DISCK
235
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$3.48M 0.1%
90,360
+606
+0.7% +$23.2K
ZTS icon
236
Zoetis
ZTS
$31.9B
$3.48M 0.1%
120,149
+4,235
+4% +$129K
COF icon
237
Capital One
COF
$129B
$3.47M 0.1%
44,999
+3,002
+7% +$220K
HRL icon
238
Hormel Foods
HRL
$14B
$3.43M 0.1%
139,342
-9,074
-6% -$209K
DFS
239
DELISTED
Discover Financial Services
DFS
$3.42M 0.1%
58,678
+676
+1% +$37.9K
ABB
240
DELISTED
ABB Ltd
ABB
$3.37M 0.1%
130,663
+15,325
+13% +$390K
GNRC icon
241
Generac Holdings
GNRC
$11.3B
$3.37M 0.1%
57,129
+2,679
+5% +$146K
FPX icon
242
First Trust US Equity Opportunities ETF
FPX
$1.49B
$3.36M 0.1%
73,141
+50,961
+230% +$2.35M
AREX
243
DELISTED
Approach Resources Inc.
AREX
$3.35M 0.1%
159,965
+21,200
+15% +$434K
ESS icon
244
Essex Property Trust
ESS
$18.1B
$3.33M 0.1%
19,593
+13,663
+230% +$2.2M
CL icon
245
Colgate-Palmolive
CL
$73.3B
$3.33M 0.1%
51,282
-930
-2% -$58.6K
TTP
246
DELISTED
TORTOISE PIPELINE & ENERGY FUND, INC.
TTP
$3.32M 0.1%
28,537
+221
+0.8% +$25.1K
CLDX icon
247
Celldex Therapeutics
CLDX
$3.02B
$3.32M 0.1%
12,532
+5,377
+75% +$2.06M
APD icon
248
Air Products & Chemicals
APD
$66.8B
$3.28M 0.1%
29,790
+22,566
+312% +$2.39M
WSM icon
249
Williams-Sonoma
WSM
$27.5B
$3.27M 0.1%
98,218
+6,140
+7% +$179K
LQD icon
250
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.3B
$3.25M 0.1%
27,760
-2,331
-8% -$270K

Similar funds

Oppenheimer & Co's Q1 2014 Portfolio in Review

As of Q1 2014, Oppenheimer & Co held 1,564 positions worth $3.34B, up 6.7% from $3.13B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Oppenheimer & Co deployed $157M of net new capital in Q1 2014, opening 189 new positions and adding to 576 existing holdings. Its largest new stake was Vanguard Morningstar Total Stock Market ETF: 169,083 shares worth $16.5M.

By sector, the portfolio is most concentrated in Energy at 12% of assets, down from 12% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Vanguard Dividend Appreciation ETF, an estimated $7.79M trimmed.

  • Oppenheimer & Co's largest Q1 2014 buy was Vanguard Morningstar Total Stock Market ETF: 169,083 shares worth $16.5M.
  • Oppenheimer & Co added most to Monsanto Co in Q1 2014, an estimated $30M increase.
  • Oppenheimer & Co's biggest Q1 2014 reduction was Vanguard Dividend Appreciation ETF, cutting an estimated $7.79M.
  • Oppenheimer & Co fully exited TetraLogic Pharmaceuticals Corporation in Q1 2014, selling an estimated $10.2M.
  • Oppenheimer & Co's ten largest holdings make up 12% of its $3.34B portfolio in Q1 2014.
  • Oppenheimer & Co opened 189 new positions and closed 163 in Q1 2014.
  • Oppenheimer & Co's portfolio value rose 6.7% quarter-over-quarter to $3.34B.

Based on Oppenheimer & Co's 13F filing for Q1 2014, filed 9 May 2014.